NEW YORK, July 24, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding The Coca-Cola Company (NYSE: KO), PepsiCo, Inc. (NYSE: PEP), Constellation Brands, Inc. (NYSE: STZ), Dr Pepper Snapple Group Inc. (NYSE: DPS) and Molson Coors Brewing Company (NYSE: TAP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5050-100free. The Coca-Cola Company Research Reports On July 15, 2014, The Coca-Cola Company (Coca-Cola) announced that its Board of Directors has declared a regular quarterly dividend of $0.305 per common share. The dividend is payable on October 1, 2014, to shareowners of record as of September 15, 2014. Coca-Cola also explained that its Board has earlier approved the 9% increase in its quarterly dividend, from $0.28 per share. The increased annual dividend is equivalent to $1.22 per share, from $1.12 per share in 2013. The full research reports on Coca-Cola are available to download free of charge at: http://www.analystsreview.com/Jul-24-2014/KO/report.pdf PepsiCo, Inc. Research Reports On July 18, 2014, PepsiCo, Inc. (PepsiCo) announced that its Board of Directors has declared a quarterly dividend of $0.655 per share of the Company's common stock. The dividend is payable on September 30, 2014, to shareholders of record as of September 5, 2014. The dividend represents a 15% YoY increase, and it is the Company's 42nd consecutive annual dividend increase. The full research reports on PepsiCo are available to download free of charge at: http://www.analystsreview.com/Jul-24-2014/PEP/report.pdf Constellation Brands, Inc. Research Reports On July 17, 2014, Constellation Brands, Inc. (Constellation) announced that its Corona Extra brand has unveiled its 2014 Limited Edition Boxing bottles collection at the recently held Canelo/Lara fight weigh-in in Las Vegas, NV. The Company explained that the specially-wrapped promotional bottles are included in the Corona Extra 18-pack bottle package. The bottles feature the image, stats, and signature of six Golden Boy boxers - Danny Garcia, Marcos Maidana, Adrien Broner, Paulie Malignaggi, Daniel Ponce de Leon, and Leo Santa Cruz. The Corona Extra Limited Edition boxing bottles are expected to be available for retail beginning August 15, 2014 through October 31, 2014. Constellation also announced that fans also stand a chance to win a VIP trip to the Mayweather vs. Maidana fight on September 13, 2014 by visiting the Corona Boxing hub website from August 9, 2014 to September 2, 2014. The full research reports on Constellation are available to download free of charge at: http://www.analystsreview.com/Jul-24-2014/STZ/report.pdf Dr Pepper Snapple Group Inc. Research Reports On July 16, 2014, Dr Pepper Snapple Group Inc. (Dr Pepper Snapple) announced that it has entered into a three-year sponsorship agreement with the San Francisco Giants, under which Snapple will have pouring rights and bring Snapple Tea and Juice drink flavors to AT&T Park. In addition, the agreement also allows Snapple to have in-stadium signage throughout the season, in-store materials with a custom Giants-related Real Fact, among other promotions. The agreement is expected to end in 2016. The full research reports on Dr Pepper Snapple are available to download free of charge at: http://www.analystsreview.com/Jul-24-2014/DPS/report.pdf Molson Coors Brewing Company Research Reports On July 11, 2014, Molson Coors Brewing Company (Molson Coors) announced that it has scheduled an online, real-time webcast of its Q2 2014 earnings conference call with financial analysts at 11:00 a.m. ET / 9:00 a.m. MT on August 6, 2014. The call will be hosted by Molson Coors CEO Peter Swinburn and CFO Gavin Hattersley. On the same day, the Company has also scheduled an online, real-time webcast of the Investor Relations Follow-up Session for financial analysts at 2:00 p.m. ET / 12:00 noon MT. The full research reports on Molson Coors are available to download free of charge at: http://www.analystsreview.com/Jul-24-2014/TAP/report.pdf About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership. EDITOR'S NOTES:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com. 5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com. 6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review